Core Viewpoint - A class action lawsuit has been filed against Marex Group PLC for allegedly making materially false and misleading statements regarding its business operations and financial statements during the Class Period from May 16, 2024, to August 5, 2025 [3][7]. Group 1: Case Details - The complaint alleges that Marex sold over-the-counter financial instruments to itself, which raises concerns about the integrity of its financial practices [3]. - It is claimed that there were inconsistencies in Marex's financial statements between its subsidiaries and related parties, particularly regarding intercompany receivables and loans [3]. - Due to these issues, the financial statements of Marex could not be relied upon, leading to misleading positive statements about the company's business and prospects [3]. Group 2: Next Steps - Investors who purchased Marex shares and suffered losses are encouraged to contact the law firm for more information about their rights and potential claims [4]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is December 8, 2025 [7]. Group 3: About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across the United States [5].

Core Points - Rosen Law Firm is reminding investors who purchased Marex Group plc securities between May 16, 2024, and August 5, 2025, of the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Company Details - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements between subsidiaries [4] - The misleading statements led to investors suffering damages when the true details were revealed [4] Legal Representation - Investors are encouraged to select qualified counsel with a successful track record in securities class actions, as many firms may not have the necessary experience or resources [3] - Rosen Law Firm has achieved significant settlements for investors, including over $438 million in 2019 and has been ranked highly for securities class action settlements [3]

Core Viewpoint - A class action securities lawsuit has been filed against Marex Group plc, alleging securities fraud that affected investors between May 16, 2024, and August 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Marex Group plc made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [2]. - As a result of these actions, the positive statements made by the defendants about the Company's business and prospects were materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1][2]. Group 1: Legal Action Details - The class period for the securities of Marex Group plc is defined as between May 16, 2024, and August 5, 2025 [1]. - Investors who purchased Marex securities during this period may be eligible for compensation without any upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors must apply to the court by December 8, 2025, to serve as lead plaintiff, representing other class members [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has consistently ranked in the top 4 for securities class action settlements since 2013 and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [4]. Group 3: Case Allegations - The lawsuit alleges that during the class period, Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - It is claimed that these misrepresentations led to investors suffering damages when the true details became public [5].

Core Viewpoint - A class action lawsuit has been filed against Marex Group plc by Berger Montague PC on behalf of investors who purchased shares during the specified Class Period, alleging financial misconduct [1][3]. Group 1: Lawsuit Details - The lawsuit claims that Marex concealed losses and inflated profits through off-balance-sheet entities and fictitious intercompany transactions, as reported by NINGI Research [3]. - Following the allegations, Marex's stock price fell by $2.33, or 6.2%, closing at $35.31, indicating significant investor losses [3]. Group 2: Company Background - Marex Group plc is a London-based global financial services company that specializes in trading, clearing, and risk management [2]. - Berger Montague, the law firm representing the plaintiffs, is known for its focus on complex civil litigation and has recovered over $50 billion for clients over its 55-year history [4].

NEW YORK, Dec. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Marex Group plc (NASDAQ: MRX).Shareholders who purchased shares of MRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/marex-group-plc-loss-submission-form/?id=179556&from=4CLASS PERIOD: May 16, 2024 to August ...

Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 8, 2025 deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the Marex Group plc securities class action is from May 16, 2024, to August 5, 2025 [1]. - Investors who purchased Marex securities during this period may be eligible for compensation without any upfront fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to serve as lead plaintiff [3]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [4]. - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company and has consistently ranked highly in securities class action settlements [4]. Group 3: Allegations Against Marex - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - It is claimed that these misrepresentations led to investors suffering damages when the true financial situation of Marex was revealed [5].

Core Viewpoint - The Rosen Law Firm is urging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit related to misleading financial statements and practices during the specified class period [1][5]. Group 1: Legal Action Details - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, may be eligible for compensation without upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to serve as lead plaintiff, representing other class members in the litigation [3]. Group 2: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Allegations Against Marex - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements among subsidiaries [5]. - As a result of these actions, Marex's financial statements were deemed unreliable, leading to misleading positive statements about the company's business and operations [5].

Core Viewpoint - A class action lawsuit has been filed against Marex Group plc, alleging significant accounting irregularities and misleading disclosures that resulted in inflated profits and concealed losses [1][3]. Summary by Sections Lawsuit Announcement - Berger Montague PC has announced a class action lawsuit on behalf of investors who purchased Marex shares from May 16, 2024, to August 5, 2025 [1][2]. Allegations - The lawsuit claims that Marex engaged in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to hide losses and inflate profits [3][4]. - Specific allegations include a fabricated $17 million receivable, a subsidiary's profits inflated by 150%, and a significant discrepancy in asset valuation, where an asset valued at $14.9 million was sold for only $2.5 million weeks later [4]. Financial Impact - Following the release of the NINGI Research report, Marex's stock price dropped by $2.33, or 6.2%, closing at $35.31, indicating substantial investor losses [5].

Core Viewpoint - Marex Group plc has completed the acquisition of Winterflood Securities, enhancing its UK cash equities business and diversifying earnings [1][2] Group 1: Acquisition Details - The acquisition of Winterflood is aligned with Marex's strategy to attract new clients and capabilities [2] - Marex will retain Winterflood's market making and corporate broking activities, with an expected annual revenue of approximately $75 million and an anticipated adjusted profit before tax margin of around 20% over time [3] Group 2: Sale of Winterflood Business Services - Marex has entered into a conditional agreement to sell Winterflood Business Services (WBS) to Epiris Fund III, with the sale expected to complete in the second quarter of 2026 [4] - The sale of WBS is seen as beneficial, as the gain from this sale will more than offset the premium paid for Winterflood, resulting in a net gain on the acquisition [4] Group 3: Company Performance and Outlook - The CEO of Marex expressed optimism about the performance in November and the overall business momentum, indicating a positive outlook for the fourth quarter and the upcoming year [4]